Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22610%22&type=Subject&page=11
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22610%22&type=Subject&page=11
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22610%22&type=Subject&page=11
PubPharm (125.682)
101
CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations : Phase 2 Study of CJNJ-67652000 (Niraparib/Abiraterone Acetate Fixed-Dose Combination) and Prednisone for Metastatic Castration-Resistant Prostate Cancer Associated With SPOP Mutation With or Without Homologous Recombination Deficiency
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
102
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma : An Open-Label, Multi-Drug, Multi-Centre, Phase II Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
103
Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity : Phase II Trial of the Combination of Alpha-lipoic Acid and Mirabegron in Women and in Men With Obesity
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
104
Trastuzumab Deruxtecan in First-line HER2-positive Locally Advanced/MBC Patients Resistant to Trastuzumab+Pertuzumab : Phase II Trial of TRAstuzumab deruxtecaN in firSt-line Treatment of HER2-positive Locally advanCEd or Metastatic Breast caNcer (MBC) Patients Considered Resistant to Trastuzumab + Pertuzumab + Taxane Due to Early Relapse."TRANSCENDER Study"
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
105
Phase II Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) : A Single-center, Randomized, Double-blind, Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of Booster Vaccination of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) in Healthy People Aged 18 Years and Older
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
106
Study Testing Benefits of Ursolic Acid (UA) as a Countermeasure To Myopenia and Insulin Resistance in Chronic Spinal Cord Injury (SCI) : A Pilot Study Testing Benefits of Ursolic Acid (UA) as a Countermeasure To Myopenia and Insulin Resistance in Chronic Spinal Cord Injury (SCI)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
107
Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism : Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism (TRAIT)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
108
A Study of Magnesium and Bladder Spasms Following Ambulatory Urologic Procedures : Magnesium and Bladder Spasms Following Ambulatory Urologic Procedures
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
109
Transcranial Direct Current Stimulation for Post-stroke Fatigue : Home-based Post-stroke Fatigue Treatment Using Transcranial Direct Current Stimulation (tDCS)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
110
Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC) : A Phase 2, Randomized Study to Evaluate the Optimized Dose, Safety, and Efficacy of Livmoniplimab in Combination With Budigalimab for Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) Patients Who Have Progressed After an Immune Checkpoint Inhibitor Containing Regimen in First-Line HCC
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
[1]
« Vorheriger
6
7
8
9
10
11
12
13
14
15
16
Nächster »
[12569]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 2
Medienart
125.682
Aufsätze
125.682
E-Artikel
125.682
E-Ressourcen
Zeitschriftentitel
72.114
WHO International Clinical Trials Registry Plat...
53.568
ClinicalTrials.gov
Thema
125.682
610
Phase: Phase 2
124.508
Study Type: Interventional
40.265
Recruitment Status: Not yet recruiting
31.971
Recruitment Status: Completed
15.315
Recruitment Status: Recruiting
15.068
Recruitment Status: Authorised-recruitment may ...
5.825
Recruitment Status: Terminated
4.486
Recruitment Status: Active, not recruiting
3.912
Recruitment Status: Complete: follow-up complete
3.263
Recruitment Status: Unknown status
3.034
Carcinoma
2.491
Breast Neoplasms
2.269
Recruitment Status: Withdrawn
1.970
Lung Neoplasms
1.936
Lymphoma
1.838
Carcinoma, Non-Small-Cell Lung
1.624
Leukemia
1.446
Syndrome
1.303
Prostatic Neoplasms
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
79.987
2020-
43.920
2010-2019
1.775
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
124.004
Englisch
868
Unbestimmt
422
Spanisch
182
Französisch
64
Deutsch
40
Dänisch
22
Italienisch
20
Sanskrit
12
Niederländisch
6
Schwedisch
4
Esperanto
4
Finnisch
4
Latein
4
Norwegisch
4
Portugiesisch
2
Corsican
2
Tschechisch
2
Estnisch
2
Frisian
2
Galizisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...